Inti Zlobec
Institute for Pathology
University Hospital Basel
Basel
Switzerland
Name/email consistency: high
- Tumor budding predicts response to anti-EGFR therapies in metastatic colorectal cancer patients. Zlobec, I., Molinari, F., Martin, V., Mazzucchelli, L., Saletti, P., Trezzi, R., De Dosso, S., Vlajnic, T., Frattini, M., Lugli, A. World J. Gastroenterol. (2010)
- Role of tumor size in the pre-operative management of rectal cancer patients. Zlobec, I., Minoo, P., Karamitopoulou, E., Peros, G., Patsouris, E.S., Lehmann, F., Lugli, A. BMC. Gastroenterol (2010)
- Prognostic and predictive value of TOPK stratified by KRAS and BRAF gene alterations in sporadic, hereditary and metastatic colorectal cancer patients. Zlobec, I., Molinari, F., Kovac, M., Bihl, M.P., Altermatt, H.J., Diebold, J., Frick, H., Germer, M., Horcic, M., Montani, M., Singer, G., Yurtsever, H., Zettl, A., Terracciano, L., Mazzucchelli, L., Saletti, P., Frattini, M., Heinimann, K., Lugli, A. Br. J. Cancer (2010)
- Combined analysis of specific KRAS mutation, BRAF and microsatellite instability identifies prognostic subgroups of sporadic and hereditary colorectal cancer. Zlobec, I., Kovac, M., Erzberger, P., Molinari, F., Bihl, M.P., Rufle, A., Foerster, A., Frattini, M., Terracciano, L., Heinimann, K., Lugli, A. Int. J. Cancer (2010)
- Tumor border configuration added to TNM staging better stratifies stage II colorectal cancer patients into prognostic subgroups. Zlobec, I., Baker, K., Minoo, P., Hayashi, S., Terracciano, L., Lugli, A. Cancer (2009)
- Combined histomorphologic and immunohistochemical phenotype to predict the presence of vascular invasion in colon cancer. Zlobec, I., Höller, S., Tornillo, L., Terracciano, L., Lugli, A. Dis. Colon Rectum (2009)
- Systematic assessment of the prognostic impact of membranous CD44v6 protein expression in colorectal cancer. Zlobec, I., Günthert, U., Tornillo, L., Iezzi, G., Baumhoer, D., Terracciano, L., Lugli, A. Histopathology (2009)
- Two-marker protein profile predicts poor prognosis in patients with early rectal cancer. Zlobec, I., Baker, K., Terracciano, L., Peter, S., Degen, L., Beglinger, C., Lugli, A. Br. J. Cancer (2008)
- Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer. Zlobec, I., Minoo, P., Baumhoer, D., Baker, K., Terracciano, L., Jass, J.R., Lugli, A. Cancer (2008)
- Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression. Zlobec, I., Baker, K., Minoo, P., Jass, J.R., Terracciano, L., Lugli, A. Clin. Cancer Res. (2008)
- Role of RHAMM within the hierarchy of well-established prognostic factors in colorectal cancer. Zlobec, I., Terracciano, L., Tornillo, L., Günthert, U., Vuong, T., Jass, J.R., Lugli, A. Gut (2008)
- Combined analysis of VEGF and EGFR predicts complete tumour response in rectal cancer treated with preoperative radiotherapy. Zlobec, I., Vuong, T., Compton, C.C., Lugli, A., Michel, R.P., Hayashi, S., Jass, J.R. Br. J. Cancer (2008)
- Value of staining intensity in the interpretation of immunohistochemistry for tumor markers in colorectal cancer. Zlobec, I., Terracciano, L., Jass, J.R., Lugli, A. Virchows Arch. (2007)